Brad Holub

Brad Holub is a highly experienced scientist and manager currently employed at Alchemab Therapeutics Ltd, where responsibilities include establishing laboratory space for the company’s first US site and managing the neuroscience team focused on in vivo study monitoring for pharmacokinetics and pharmacodynamics. Previously, Brad worked at UCB Ra Pharma and its predecessor Ra Pharmaceuticals as the sole in vivo researcher, developing pharmacological models and managing in-house PK studies. Early career experience includes positions at Takeda Oncology and Takeda Pharmaceuticals, performing various in vitro and in vivo experiments, and starting as a Senior Staff Animal Care Specialist at Countryside Veterinary Hospital. Brad Holub holds a Master's degree in Biomedical Sciences from Regis College and a Bachelor's degree in Biology from the University of Massachusetts Amherst.